16 reports of this reaction
1.2% of all HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK reports
#7 most reported adverse reaction
GLOSSODYNIA is the #7 most commonly reported adverse reaction for HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, manufactured by Boiron. There are 16 FDA adverse event reports linking HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK to GLOSSODYNIA. This represents approximately 1.2% of all 1,361 adverse event reports for this drug.
Patients taking HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK who experience glossodynia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GLOSSODYNIA is a less commonly reported adverse event for HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, but still significant enough to appear in the safety profile.
In addition to glossodynia, the following adverse reactions have been reported for HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK:
The following drugs have also been linked to glossodynia in FDA adverse event reports:
GLOSSODYNIA has been reported as an adverse event in 16 FDA reports for HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK. This does not prove causation, but indicates an association observed in post-market surveillance data.
GLOSSODYNIA accounts for approximately 1.2% of all adverse event reports for HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, making it a notable side effect.
If you experience glossodynia while taking HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.